A research group led by Osaka Metropolitan University has studied how SGLT2 inhibitors, a class of drugs that help the ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...

November is National Diabetes Awareness Month and the American Diabetes Association is reporting that people with diabetes ...

November is Diabetes and Kidney Disease Awareness month, and a great time to find out how you can protect yourself from a ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

Discover how SGLT-2 inhibitors improve survival and reduce cardiac and kidney risks in diabetic kidney transplant recipients.